Tamoxifen induction of angiogenic factor expression in endometrium

Tamoxifen is the current therapy of choice for patients with oestrogen receptor positive breast cancer, and it is currently under evaluation as a prophylactic for women at high risk of developing the disease. However, tamoxifen is also known to induce proliferative changes in the endometrium increas...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hague, S, Manek, S, Oehler, M K, MacKenzie, I Z, Bicknell, R, Rees, M C P
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2002
Fag:
Molecular and Cellular Pathology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375303/
https://ncbi.nlm.nih.gov/pubmed/11875740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600157
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker